Ikapharmindo Putramas Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 2.3× Ikapharmindo Putramas Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 13.7K). Which is the better fit depends on your goals.
| IKPM | RSCH | |
|---|---|---|
Market Cap | 304.92B | 715.5B |
Volume | 13.7K | 30.64M |
Lot | 137 | 306.41K |
Turnover | 2.49M | 7.98B |
Average Price | 181.39 | 260.34 |
Value | 2.49M | 7.98B |
Indicative Equilibrium Price | — | 256 |
Indicative Equilibrium Volume | — | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →